Atlas Trials

COMPASS Pathways

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch COMPASS Pathways

RecordFirmDate
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder (NCT07570654)COMPASS Pathways2026-09-01
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD (NCT05711940)COMPASS Pathways2023-02-14
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder (NCT05733546)COMPASS Pathways2023-01-30
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD (NCT05624268)COMPASS Pathways2023-01-24
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study (NCT05481736)COMPASS Pathways2022-10-12
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder (NCT05312151)COMPASS Pathways2022-06-10
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression (NCT04739865)COMPASS Pathways2020-08-10
Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU) (NCT04519957)COMPASS Pathways2020-07-20
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression (NCT03775200)COMPASS Pathways2019-03-01

Track COMPASS Pathways automatically

Every clearance here is in the API, with alerts when new ones post.